business

Cell Therapy

S.biomedic’s autologous fibroblast therapy, Cureskin, received KFDA approval in year 2010. The Cureskin is a subcutaneous injection of 2x107cells/ml. It is mainly
used for depressed acne scars and improvement of facial wrinkles.

Autologous Dermal Fibroblast

Indication: Depressed Acne Scar

Intra-dermal injection

Dose: 2×107 cells/ml

Usage: 3times injection, biweekly

CMO

icon

Production of various cell therapy products

arrow
icon

Cell therapy quality control tests

arrow
icon

Production process establishment and validation

arrow
icon

Establishing standardization and testing methods

arrow
icon

Test method validation

Cell Banking

– Autologous skin fibroblasts and fibroblast microtissue cryopreservation and storage

– Shelf life: 7 years

Conditioned Culture Media Cosmetic

Cosmetic product containing various growth factors
(EGF, VEGF, FGF, HGF, PDGF, etc) and fibroblast
conditioned media which are responsible for skin
elasticity and whitening.